Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.5400-0.0800 (-2.21%)
At close: 04:00PM EST
3.5400 0.00 (0.00%)
After hours: 04:41PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.13
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 311.4200
52 Week Low 33.1500
50-Day Moving Average 33.9680
200-Day Moving Average 35.4618

Share Statistics

Avg Vol (3 month) 391.52k
Avg Vol (10 day) 395.97k
Shares Outstanding 59.98M
Implied Shares Outstanding 6N/A
Float 88.8M
% Held by Insiders 12.14%
% Held by Institutions 144.58%
Shares Short (Dec 14, 2021) 4366.19k
Short Ratio (Dec 14, 2021) 43.53
Short % of Float (Dec 14, 2021) 43.70%
Short % of Shares Outstanding (Dec 14, 2021) 43.67%
Shares Short (prior month Nov 14, 2021) 4488.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 14, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Apr 14, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-33.88%
Return on Equity (ttm)-49.84%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-4.76M
EBITDA -19.53M
Net Income Avi to Common (ttm)-20.37M
Diluted EPS (ttm)-2.6570
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)40.22M
Total Cash Per Share (mrq)4.03
Total Debt (mrq)44k
Total Debt/Equity (mrq)0.11
Current Ratio (mrq)12.08
Book Value Per Share (mrq)4.22

Cash Flow Statement

Operating Cash Flow (ttm)-15.14M
Levered Free Cash Flow (ttm)-9.74M
Advertisement
Advertisement